Dominik Schumacher
13PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Aug 20, 2025
TUB-010, a Novel Anti-CD30 Antibody-Drug Conjugate Based on Tub-Tag Technology, Widens the Therapeutic Window by Reducing Toxicity While Maintaining High Efficacy.Marcus Gerlach, Saskia Schmitt, Philipp Cyprys
|Jul 16, 2025
TUB-040, a Homogeneous and Hydrophilic NaPi2b-Targeting ADC with Stably Linked Exatecan, Exhibits Long-lasting Antitumor Activity and a Well-Tolerated Safety Profile.Annette M Vogl, Saskia Schmitt, Isabelle Mai
|May 05, 2025
Orthogonal Site-Specific Dual Bioconjugation of Aryl and Alkyl Thiols.Mark A R de Geus, Christian E Stieger, Jan Vincent V Arafiles
|Jan 27, 2025
Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates.Marina Able, Marc-André Kasper, Binje Vick
|Oct 13, 2023
Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody-Drug Conjugates.Saskia Schmitt, Paul Machui, Isabelle Mai
|Aug 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML.Maike Roas, Binje Vick, Marc-André Kasper
Pageof 3
Frequent Collaborators
9 joint publications
Christian P R Hackenberger
6 joint publications
Marc-André Kasper
5 joint publications
Jonas Helma
5 joint publications
Heinrich Leonhardt
5 joint publications
Saskia Schmitt
4 joint publications
Marcus Gerlach
3 joint publications
Philipp Ochtrop
3 joint publications
Isabelle Mai
3 joint publications
Philipp Cyprys
3 joint publications
Annette M Vogl
